Corvus Pharmaceuticals
CRVS
CRVS
54 hedge funds and large institutions have $280M invested in Corvus Pharmaceuticals in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 19 increasing their positions, 16 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.19% more ownership
Funds ownership: 83.59% → 83.78% (+0.19%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
54
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$2.95M | |
| 2 | +$1.65M | |
| 3 | +$1.35M | |
| 4 |
Renaissance Technologies
New York
|
+$912K |
| 5 |
TI
Telemetry Investments
New York
|
+$430K |
Top Sellers
| 1 | -$3.13M | |
| 2 | -$2.01M | |
| 3 | -$617K | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$595K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$578K |